Mori JO, Shafran JS, Stojanova M, Katz MH, et al. Novel forms of prostate cancer chemoresistance to successful androgen deprivation therapy demand new approaches: Rationale for targeting BET proteins. Prostate 2022 Apr 11. doi: 10.1002/pros.24351.
PMID: 35403746